封面
市場調查報告書
商品編碼
1477100

藥物洗脫塗層市場,按類型、應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Drug-Eluting Coating Market, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 289 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年藥物洗脫塗層市場規模為27.8934億美元,2024年至2032年複合年成長率為8.7%。

藥物洗脫塗層市場-市場動態

對微創手術的需求不斷成長推動市場成長

由於微創手術的需求不斷增加,預計該市場將會成長,微創手術透過使用藥物洗脫支架和小切口來修復受限或阻塞的冠狀動脈。例如,2023年1月,美國國家醫學圖書館發表文章稱,美國每年進行的微創手術病例數超過300萬例。這些手術有幾個好處,包括更少的身體創傷、更快的恢復期、更短的住院時間和更少的問題。因此,由於對微創手術的需求增加,預計藥物洗脫支架市場將會發展。

藥物洗脫塗層市場 - 關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2024-2032 年)每年將以 8.7% 左右的複合年成長率成長

根據類型細分,藥物輸送塗料領域預計將在預測期內佔據最大的收入佔有率

根據應用細分,預計醫院領域將在預測期內主導市場

從地區來看,預計北美將在預測期內主導市場

藥物洗脫塗層市場-細分分析:

全球藥物洗脫塗層市場根據類型、應用和地區進行細分。

根據類型,藥物洗脫塗層市場分為藥物傳輸塗層、生物相容性塗層和無聚合物塗層/表面。預計藥物輸送塗料領域將在預測期內佔據最大的收入佔有率。此細分市場的成長是由於慢性病盛行率上升。隨著糖尿病、癌症和心血管疾病等全球慢性疾病負擔的增加,帶有藥物洗脫塗層的創新醫療設備越來越受歡迎。這些設備旨在改善患者的生活品質和治療結果。

根據應用,全球藥物洗脫塗層市場分為研究所和醫院。預計醫院部門將在預測期內主導市場。對微創手術不斷成長的需求推動了該細分市場的成長。

藥物洗脫塗層市場 - 地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美將在預測期內主導市場。完善的醫療基礎設施和藥物洗脫支架技術的發展也推動了市場的擴張。例如,在10 年預測風險較高的族群中,動脈粥狀硬化性心血管疾病的發生率為每1,000 人年2.60 人;在10 年預測風險較低但30 年預測風險較高的族群中,動脈粥狀硬化性心血管疾病的發生率為1.87 人年;在10 年預測風險較高的人群中,動脈粥狀硬化性心血管疾病的發生率為每1000 人年0.32 人年。 2 月出版的《美國心臟病學會雜誌》,美國10 年和30 年的預測風險較低。推動區域市場拓展。

藥物洗脫塗層市場-競爭格局:

市場上的主要參與者包括 Covalon Technologies Ltd.、Carmeda AB、AST Products, Inc.、Biophan Technologies, Inc.、Biocoat, Inc.、Hemoteq AG、Armoloy of Connecticut, Inc.、Nanocopoeia, Inc.、Hydromer、 Inc . 和N2 生物醫學。這些參與者採取了各種策略來獲得該行業的主要市場佔有率,包括產品發布、收購、合作等。

最新進展:

2023年6月,美國FDA核准了SurVeilTM藥物塗層球囊(DCB)。 Surmodics, Inc. 是一家為醫療保健產業提供醫療設備和體外診斷技術的著名供應商。

目錄

第 1 章:藥物洗脫塗層市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 按類型分類的藥物洗脫塗層市場片段
    • 藥物洗脫塗層市場片段(依應用)
    • 按國家/地區分類的藥物洗脫塗層市場片段
    • 按地區分類的藥物洗脫塗層市場片段
  • 競爭洞察

第 3 章:藥物洗脫塗層主要市場趨勢

  • 藥物洗脫塗層市場促進因素
    • 市場促進因素的影響分析
  • 藥物洗脫塗層市場限制
    • 市場限制影響分析
  • 藥物洗脫塗層市場機會
  • 藥物洗脫塗層市場未來趨勢

第 4 章:藥物洗脫塗層產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:藥物洗脫塗層市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:藥物洗脫塗層市場格局

  • 2023 年藥物洗脫塗層市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:藥物洗脫塗層市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 藥物輸送塗層
    • 生物相容性塗層
    • 無聚合物塗層/表面

第 8 章:藥物洗脫塗層市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 研究機構
    • 醫院

第 9 章:藥物洗脫塗層市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美藥物洗脫塗層主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按類型)
    • 北美市場規模和預測(按應用)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲藥物洗脫塗層主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模與預測(按類型)
    • 歐洲市場規模和預測(按應用)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區藥物洗脫塗層主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(按類型)
    • 亞太地區市場規模與預測(按應用)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲藥物洗脫塗層主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按類型)
    • 拉丁美洲市場規模與預測(按應用)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲藥物洗脫塗層主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按類型)
    • 中東和非洲市場規模及預測(按應用)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章:主要供應商分析 - 藥物洗脫塗層產業

  • 競爭儀表板
  • 公司簡介
    • Covalon Technologies Ltd.
    • Carmeda AB
    • AST Products, Inc.
    • Biophan Technologies, Inc.
    • Biocoat, Inc.
    • Hemoteq AG
    • Armoloy of Connecticut, Inc.
    • Nanocopoeia, Inc.
    • Hydromer, Inc.
    • N2 Biomedical

第 11 章:360 度分析師視角

第 12 章:附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2496

REPORT HIGHLIGHT

Drug-Eluting Coating Market size was valued at USD 2,789.34 Million in 2023, expanding at a CAGR of 8.7% from 2024 to 2032.

When a particular layer is placed on medical equipment, such as implants or stents, it's called a drug-eluting coating. Its purpose is to release medication gradually. These coatings can promote healing, lessen inflammation, stop infection, or stop the growth of scar tissue, among other functions. These coatings can lower the risk of problems and increase the efficacy of the device by releasing medications gradually at the site of implantation. The medications used and the coating's formulation is based on the particular medical application and the intended therapeutic results.

Drug-Eluting Coating Market- Market Dynamics

Increasing demand for minimally invasive surgeries drives market growth

The market is anticipated to rise due to the increasing demand for minimally invasive operations, which repair restricted or blocked coronary arteries by employing drug-eluting stents and small incisions. In January 2023, for instance, the National Library of Medicine issued an article stating that the number of cases of minimally invasive surgery performed in the US each year exceeded three million. These operations have several benefits, including less physical trauma, quicker recovery periods, shorter hospital stays, and fewer problems. As a result, the market for drug-eluting stents is expected to develop due to the increased demand for minimally invasive procedures.

Drug-Eluting Coating Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.7% over the forecast period (2024-2032)

Based on type segmentation, the Drug-delivery Coatings segment is expected to capture the largest revenue share over the projected period

Based on application segmentation, the hospital segment is expected to dominate the market over the projected period

Based on region, North America is expected to dominate the market over the forecast period

Drug-Eluting Coating Market- Segmentation Analysis:

The Global Drug-Eluting Coating Market is segmented based on Type, Application and Region.

Based on the type, the Drug-Eluting Coating market is bifurcated into Drug-delivery Coatings, Biocompatible Coatings and Polymer-free Coatings/Surfaces. The Drug-delivery Coatings segment is expected to capture the largest revenue share over the projected period. The segment increase is owing to the rising prevalence of chronic disease. Innovative medical devices with drug-eluting coatings are in increasing popularity as the worldwide burden of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, rises. These devices aim to improve patient quality of life and treatment outcomes.

Based on the application, the global Drug-Eluting Coating market is segmented into Research Institute and Hospital. The Hospital segment is expected to dominate the market over the projected period. The growing demand for minimally invasive surgery driving the segment growth.

Drug-Eluting Coating Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The existence of well-established healthcare infrastructure and technological developments in drug-eluting stents are also driving the market's expansion. For example, the incidence rate of atherosclerotic cardiovascular disease was 2.60 per 1,000 person-years among those with a raised 10-year predicted risk, 1.87 in those with a low 10-year but elevated 30-year predicted risk, and 0.32 in those with low 10-year and 30-year predicted risk in the United States, according to the Journal of the American College of Cardiology published in February 2023. As a result, the increased prevalence of atherosclerotic cardiovascular disease raises the need for drug-eluting stent therapy, which propels regional market expansion.

Drug-Eluting Coating Market- Competitive Landscape:

The key players operating in the market are Covalon Technologies Ltd., Carmeda AB, AST Products, Inc., Biophan Technologies, Inc., Biocoat, Inc., Hemoteq AG, Armoloy of Connecticut, Inc., Nanocopoeia, Inc., Hydromer, Inc. and N2 Biomedical. These players adopted various strategies to gain major market share in the industry including product launches, acquisitions, collaboration and others.

Recent Development:

In June 2023, The FDA in the United States approved the SurVeilTM drug-coated balloon (DCB). Surmodics, Inc. is a prominent supplier of medical devices and in vitro diagnostic technologies to the healthcare sector.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL Drug-Eluting Coating MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Covalon Technologies Ltd.

Carmeda AB

AST Products, Inc.

Biophan Technologies, Inc.

Biocoat, Inc.

Hemoteq AG

Armoloy of Connecticut, Inc.

Nanocopoeia, Inc.

Hydromer, Inc.

N2 Biomedical

GLOBAL Drug-Eluting Coating MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Drug-delivery Coatings
  • Biocompatible Coatings
  • Polymer-free Coatings/Surfaces

GLOBAL Drug-Eluting Coating MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Research Institute
  • Hospital

GLOBAL Drug-Eluting Coating MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Drug-Eluting Coating Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Drug-Eluting Coating Market Snippet by Type
    • 2.1.2.Drug-Eluting Coating Market Snippet by Application
    • 2.1.3.Drug-Eluting Coating Market Snippet by Country
    • 2.1.4.Drug-Eluting Coating Market Snippet by Region
  • 2.2.Competitive Insights

3.Drug-Eluting Coating Key Market Trends

  • 3.1.Drug-Eluting Coating Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Drug-Eluting Coating Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Drug-Eluting Coating Market Opportunities
  • 3.4.Drug-Eluting Coating Market Future Trends

4.Drug-Eluting Coating Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Drug-Eluting Coating Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Drug-Eluting Coating Market Landscape

  • 6.1.Drug-Eluting Coating Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Drug-Eluting Coating Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Drug-delivery Coatings
    • 7.1.3.Biocompatible Coatings
    • 7.1.4.Polymer-free Coatings/Surfaces

8.Drug-Eluting Coating Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Research Institute
    • 8.1.3.Hospital

9.Drug-Eluting Coating Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Drug-Eluting Coating Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Drug-Eluting Coating Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Drug-Eluting Coating Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Drug-Eluting Coating Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Drug-Eluting Coating Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Drug-Eluting Coating Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Covalon Technologies Ltd.
    • 10.2.2.Carmeda AB
    • 10.2.3.AST Products, Inc.
    • 10.2.4.Biophan Technologies, Inc.
    • 10.2.5.Biocoat, Inc.
    • 10.2.6.Hemoteq AG
    • 10.2.7.Armoloy of Connecticut, Inc.
    • 10.2.8.Nanocopoeia, Inc.
    • 10.2.9.Hydromer, Inc.
    • 10.2.10.N2 Biomedical

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Drug-Eluting Coating Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Drug-Eluting Coating Market, by Type 2019-2032 (USD Million)
  • TABLE Drug-Eluting Coating Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Drug-Eluting Coating Market, by Application 2019-2032 (USD Million)
  • TABLE Drug-Eluting Coating Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Drug-Eluting Coating Market, by Region 2019-2032 (USD Million)
  • TABLE North America Drug-Eluting Coating Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Drug-Eluting Coating Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Drug-Eluting Coating Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Drug-Eluting Coating Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Drug-Eluting Coating Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Drug-Eluting Coating Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug-Eluting Coating Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug-Eluting Coating Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Drug-Eluting Coating Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Drug-Eluting Coating Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Drug-Eluting Coating Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Drug-Eluting Coating Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug-Eluting Coating Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug-Eluting Coating Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Drug-Eluting Coating Market, by Application, 2019-2032 (USD Million)